Matthew Plassmeyer

Flometrics (United States) — United States

Medicine · Health Sciences

17h-index1.1kcitations34works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(7), Food Allergy and Anaphylaxis Research(7), SARS-CoV-2 and COVID-19 Research(5), Mosquito-borne diseases and control(5), Lysosomal Storage Disorders Research(5)

Publications34 total

Dupilumab opens a therapeutic window in food protein–induced enterocolitis syndrome by unlicensing dendritic cells
Journal of Allergy and Clinical Immunology Global·2025Open Access
Enhancing allergy diagnosis: mass spectrometry as a complementary technique to the basophil activation test
Frontiers in Allergy·2025Open Access
Basophil activation test; User's manual
Journal of Immunological Methods·2025· 5 cited
Basophil Activation Test; User's Manual
SSRN Electronic Journal·2024Open Access
STAT4 Phosphorylation of T-helper Cells predicts surgical outcomes in Refractory Chronic Rhinosinusitis
2023· 1 citedOpen Access
Towards standardizing basophil identification by flow cytometry
Frontiers in Allergy·2023· 21 citedOpen Access
Towards an FDA-cleared basophil activation test
Frontiers in Allergy·2023· 19 citedOpen Access
Caspases and therapeutic potential of caspase inhibitors in moderate–severe SARS‐CoV‐2 infection and long COVID
Allergy·2021· 60 citedOpen Access
Caspases in COVID-19 disease and sequela and the therapeutic potential of caspase inhibitors
2021· 7 citedOpen Access
Validation of inducible basophil biomarkers: Time, temperature and transportation
Cytometry Part B Clinical Cytometry·2021· 17 citedOpen Access
SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
Communications Biology·2021· 131 citedOpen Access
CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14
International Journal of Infectious Diseases·2020· 146 citedOpen Access
Caspases in COVID-19 Disease and Sequela and the Therapeutic Potential of Caspase Inhibitors
2020· 1 citedOpen Access
Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19
2020· 32 citedOpen Access
Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19
Journal of Hepatology·2020· 34 citedOpen Access
Altered immune phenotypes in subjects with Fabry disease and responses to switching from agalsidase alfa to agalsidase beta.
PubMed·2019· 16 citedOpen Access
Improved panels for clinical immune phenotyping: Utilization of the violet laser
Cytometry Part B Clinical Cytometry·2017· 10 citedOpen Access
Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease
PLoS ONE·2016· 33 citedOpen Access
Novel IL12Rβ1 mutation impairs Th1 response in heterozygote patient.
The Journal of Immunology·2016
Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease
Blood Cells Molecules and Diseases·2016· 22 cited
page 1 of 2Next →

Frequent Co-authors

Oral Alpan(25), Søren Ulrik Sønder(12), Raavi Gupta(10), Denise Loizou(9), Renuka P. Limgala(6), Mark Ryherd(6), Paige Coatney(5), Kimberleigh Lillard(5), Zaheer Bukhari(5), Özlem Göker-Alpan(5), Alina P.S. Pang(4), Philip A. Mudd(4), Lishomwa C. Ndhlovu(4), Lina Kozhaya(4), Derya Unutmaz(4), Francisco González‐Scarano(4), Mikell Paige(4), Michael Girgis(4), Michael J. Corley(3), Mikail Dogan(3)